SEC Form 4 · accession 0001179110-17-000410
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sujal Shah
Officer — Chief Financial Officer
Period of report
Dec 30, 2016
Accepted (ET)
Jan 4, 2017 · 8:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.82 | Dec 30, 2016 | A | 25,000 | A | Dec 30, 2016 | Jul 24, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1On July 25, 2016, the Reporting Person was granted an option to purchase 50,000 shares of common stock of the Issuer. The option vests in two equal installments based on the Issuer's achieving certain milestones. The first milestone was met, resulting in vesting of the option as to 25,000 shares.